Trial Profile
Retrospective study of Clinical utility (included pain evaluation) by monthly minodronic acid hydrate for Osteoporosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms MIN-M
- 31 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 11 Feb 2013 New trial record